Scholarlink

Purpose <p>To present the World Health Organization’s (WHO) multi‑stage methodology used in the 2024 Compendium of Innovative Health Technologies for Low‑Resource Settings and provide a replicable framework for decision‑makers.</p> Methods <p>Α five‑step process is described covering call preparation, open call and screening, multi‑domain assessment, cross‑checking and final approval, and selection. Evidence‑based assessments were conducted across six areas—clinical need, comparison with WHO technical specifications (MeDevIS), regulatory status (WHO/IMDRF), health technology assessment (HTA), health technology management (HTM), and intellectual property &amp; local production (IP/LP)—using standardized forms and an online innovations assessment database. Evaluations were iterated with feedback from WHO staff and the Strategic Advisory Group on Medical Devices and Health Technologies (STAG MEDEV).</p> Results <p>In the 2023/24 cycle, 225 submissions were received; 62 technologies underwent full evaluation by multidisciplinary external panels. Following deliberation and validation, 28 technologies were listed (13 commercially available, 3 newly commercialized, 4 prototypes, 1 reassessment, and 7 minor updates), reflecting transparent criteria and consensus‑driven decisions.</p> Conclusions <p>The WHO methodology operationalizes rigorous, transparent, and context‑appropriate evaluation of health technologies for low‑resource settings. By integrating clinical, regulatory, economic, managerial, and IP/LP perspectives, it supports adoption decisions that balance effectiveness, feasibility, and sustainability. The standardized tools and workflows are readily adaptable by ministries of health and procurement bodies to strengthen technology selection processes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The WHO methodology framework to assess innovative technologies for low-resource settings

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月30日

查看全文
  • Aris Dermitzakis,
  • César Burgi Vieira,
  • Luis Mario Juarez,
  • Einstein Albert Kesi,
  • Sara K. Liaghati-Mobarhan,
  • Debjani Mueller,
  • Nicolas Pallikarakis,
  • Jillian Reichenbach Ott,
  • Daniela Rodríguez Rodríguez,
  • Sasikala Devi Thangavelu,
  • Adriana Velazquez Berumen

摘要

Purpose

To present the World Health Organization’s (WHO) multi‑stage methodology used in the 2024 Compendium of Innovative Health Technologies for Low‑Resource Settings and provide a replicable framework for decision‑makers.

Methods

Α five‑step process is described covering call preparation, open call and screening, multi‑domain assessment, cross‑checking and final approval, and selection. Evidence‑based assessments were conducted across six areas—clinical need, comparison with WHO technical specifications (MeDevIS), regulatory status (WHO/IMDRF), health technology assessment (HTA), health technology management (HTM), and intellectual property & local production (IP/LP)—using standardized forms and an online innovations assessment database. Evaluations were iterated with feedback from WHO staff and the Strategic Advisory Group on Medical Devices and Health Technologies (STAG MEDEV).

Results

In the 2023/24 cycle, 225 submissions were received; 62 technologies underwent full evaluation by multidisciplinary external panels. Following deliberation and validation, 28 technologies were listed (13 commercially available, 3 newly commercialized, 4 prototypes, 1 reassessment, and 7 minor updates), reflecting transparent criteria and consensus‑driven decisions.

Conclusions

The WHO methodology operationalizes rigorous, transparent, and context‑appropriate evaluation of health technologies for low‑resource settings. By integrating clinical, regulatory, economic, managerial, and IP/LP perspectives, it supports adoption decisions that balance effectiveness, feasibility, and sustainability. The standardized tools and workflows are readily adaptable by ministries of health and procurement bodies to strengthen technology selection processes.